BioCentury
ARTICLE | Company News

TNI BioTech, LDN Research deal

January 14, 2013 8:00 AM UTC

TNI BioTech received exclusive rights to patents developed by Dr. Jill Smith and LDN relating to treatments for opioid antagonists, such as naltrexone, to treat inflammatory and ulcerative diseases of...